Triple
T219129
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Department of Health and Social Care |
E4174
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
NHS Blood and Transplant
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
|
E28059
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NHS Blood and Transplant | Statement: [Department of Health and Social Care, oversees, NHS Blood and Transplant]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NHS Blood and Transplant Context triple: [Department of Health and Social Care, oversees, NHS Blood and Transplant]
-
A.
Cambridge University Hospitals NHS Foundation Trust
Cambridge University Hospitals NHS Foundation Trust is a major NHS teaching and research hospital group in Cambridge, England, that provides specialist and general healthcare services in partnership with the University of Cambridge.
-
B.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
C.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
D.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
E.
Banting Research Foundation
The Banting Research Foundation is a Canadian organization that funds early-career health and biomedical researchers, established to honor and continue the scientific legacy of insulin co-discoverer Sir Frederick Banting.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NHS Blood and Transplant Triple: [Department of Health and Social Care, oversees, NHS Blood and Transplant]
Generated description
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: NHS Blood and Transplant Target entity description: NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
-
A.
Cambridge University Hospitals NHS Foundation Trust
Cambridge University Hospitals NHS Foundation Trust is a major NHS teaching and research hospital group in Cambridge, England, that provides specialist and general healthcare services in partnership with the University of Cambridge.
-
B.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
C.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
D.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
E.
Banting Research Foundation
The Banting Research Foundation is a Canadian organization that funds early-career health and biomedical researchers, established to honor and continue the scientific legacy of insulin co-discoverer Sir Frederick Banting.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a2573508588190b522c2476d91acfe |
completed | Feb. 28, 2026, 2:47 a.m. |
| NER | Named-entity recognition | batch_69a25c5199d8819096736c11077adec3 |
completed | Feb. 28, 2026, 3:09 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a3476fe7a0819086ce5c028429b2c0 |
completed | Feb. 28, 2026, 7:52 p.m. |
| NEDg | Description generation | batch_69a34a3ad4688190acdcca286cd8a19a |
completed | Feb. 28, 2026, 8:04 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69a34a97c5dc8190b0f3e4f3c342cfae |
completed | Feb. 28, 2026, 8:05 p.m. |
Created at: Feb. 28, 2026, 2:53 a.m.